Subscribe below to get free access to our latest newsletter and watch our product video
A patient preference study of Crohn’s disease treatments, carried out by Semalytix and partner Boehringer Ingelheim, has won a...
Tags: Semalytix, Patient Listening, Pharma,
Tags: Semalytix, AI, Healthcare,
Patients’ voices are no longer a nice-to-have in drug development. They are a critical determinant of commercial success. As...
Tags: Semalytix, Patient Listening, Health
Improving Pharma’s Ability to Focus on the Needs of Key Stakeholders
Executive Summary
By Melanie Senior, Analyst and Specialist, Writer in Pharma, Life Sciences
Tags: Semalytix
The knowledge graph developed by Semalytix comprises of millions of pharma-relevant entities modeling key knowledge about...
Tags: Semalytix
Looking at Market Access for the pharmaceutical industry through the eyes of somebody involved in machine learning and...
Tags: Semalytix
At Semalytix, we are developing cutting-edge technology for machine reading, allowing machines to automatically sift through...
Tags: Semalytix
You can allow them to download an ebook, subscribe to your mailing list or book a meeting with sales in exchange for their contact information, turning them into leads for your business.
Semalytix GmbH
Meller Str. 2
33613 Bielefeld
Germany
Call: +49-521-9145-6127
Email: info@semalytix.com
Court of Registration:
Amtsgericht Bielefeld HRB 41831
Value Added Tax ID no.:
DE 300921056
Management Board:
Janik Jaskolski
All rights reserved © 2019 Semalytix GmbH